Lasa Supergenerics reports standalone net loss of Rs 6.61 crore in the September 2022 quarter

Urja Global Ltd, Ansal Housing Ltd, Butterfly Gandhimathi Appliances Ltd and Indo Amines Ltd are among the other gainers in the BSE’s ‘B’ group today, 22 July 2022.

Lasa Supergenerics Ltd leads gainers in ‘B’ group

Motor & General Finance Ltd, Lasa Supergenerics Ltd, Patel Integrated Logistics Ltd and Rudra Global Infra Products Ltd are among the other gainers in the BSE’s ‘B’ group today, 01 July 2022.

Wardwizard Innovations & Mobility Ltd PartlyPaidup leads gainers in ‘B’ group

Buzzing stocks: Wipro, Reliance Industries, Omaxe, Adani Enterprises, Tata Elxsi, Lasa Supergenerics, AU Small Finance Bank, Care Ratings, JK Agri Genetics, Mahindra Logistics, Indian Overseas Bank

Stocks that will see action on April 27, 2022

Lasa Supergenerics standalone net profit rises 223.16% in the March 2022 quarter

Lasa Supergenerics surged 16.91% to Rs 63.25 after the company’s net profit surged to Rs 12.28 crore in Q4 FY22 from Rs 3.79 crore in Q4 FY21.

Lasa Supergenerics soars after stellar Q4 performance

The company reported that its revenues from operations stood at Rs51.21 crore in Q4FY22 as compared to Rs15.74 crore in Q3FY22, up by 225% sequentially.

Lasa Supergenerics logs 362% sequential growth in PAT in Q4FY22; stock skyrockets ~15%

Buzzing stocks: Tata Motors, Adani Green Energy, Adani Transmission, Adani Enterprises, Wipro, SMS Life, RITES, Seamac, Escorts,Shree Krishna Paper, Mahindra Logostics, Sandur Manganese, Delta Corp, Hathway Cable, Kesoram, Lasa Supergenerics

Stocks that will see action on April 11

Tata Consultancy Services, Birla Tyres, Delta Corp, Elnet Technologies, Kesoram Industries, and Lasa Supergenerics will announce their quarterly earnings on Monday

Stocks to Watch: TCS, Tata Motors, Tata Steel, Axis Bank, Vodafone Idea

Capital Trust Ltd, Future Supply Chain Solutions Ltd, Intense Technologies Ltd and Lasa Supergenerics Ltd are among the other gainers in the BSE’s ‘B’ group today, 30 March 2022.

Gayatri Projects Ltd leads gainers in ‘B’ group

Lasa Supergenerics reports standalone net loss of Rs 4.71 crore in the December 2021 quarter

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Average profitability - not good, not bad

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Lasa Supergenerics Limited is engaged in the manufacturing of anthelmintics/veterinary active pharmaceutical ingredient (API). The Company also manufactures bulk drugs